593 related articles for article (PubMed ID: 34958385)
21. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
22. Hormones modulate Candida vaginal isolates biofilm formation and decrease their susceptibility to azoles and hydrogen peroxide.
Gonçalves B; Azevedo NM; Henriques M; Silva S
Med Mycol; 2020 Apr; 58(3):341-350. PubMed ID: 31254346
[TBL] [Abstract][Full Text] [Related]
23. Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Pang Q; Liu W; Cui F; Kan S; Li X
Mycopathologia; 2022 Dec; 187(5-6):427-437. PubMed ID: 36209322
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases.
Faria-Gonçalves P; Gaspar C; Oliveira AS; Palmeira-de-Oliveira R; Gonçalves T; Martinez-de-Oliveira J; Palmeira-de-Oliveira A; Rolo J
Med Mycol; 2021 Dec; 59(12):1166-1173. PubMed ID: 34427667
[TBL] [Abstract][Full Text] [Related]
25. Cell-free supernatants of probiotic consortia impede hyphal formation and disperse biofilms of vulvovaginal candidiasis causing Candida in an ex-vivo model.
Kumar SAS; Krishnan D; Jothipandiyan S; Durai R; Hari BNV; Nithyanand P
Antonie Van Leeuwenhoek; 2024 Feb; 117(1):37. PubMed ID: 38367023
[TBL] [Abstract][Full Text] [Related]
26. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
[TBL] [Abstract][Full Text] [Related]
27. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Diagn Microbiol Infect Dis; 2024 May; 109(1):116242. PubMed ID: 38452558
[TBL] [Abstract][Full Text] [Related]
29. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
30. Differential Response of
Salama OE; Gerstein AC
Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
32. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
[TBL] [Abstract][Full Text] [Related]
33. Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
Nikoomanesh F; Falahatinejad M; Černáková L; Dos Santos ALS; Mohammadi SR; Rafiee M; Rodrigues CF; Roudbary M
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109701
[No Abstract] [Full Text] [Related]
34. Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?
Nakamura-Vasconcelos SS; Fiorini A; Zanni PD; Bonfim-Mendonça PS; Godoy JR; Almeida-Apolonio AA; Consolaro MEL; Svidzinski TIE
Arch Gynecol Obstet; 2017 Sep; 296(3):519-526. PubMed ID: 28730269
[TBL] [Abstract][Full Text] [Related]
35. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
[TBL] [Abstract][Full Text] [Related]
36. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
[TBL] [Abstract][Full Text] [Related]
37. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
[TBL] [Abstract][Full Text] [Related]
38. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
Boahen A; Chew SY; Neela VK; Than LTL
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
40. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.
Jothi R; Hong ST; Enkhtsatsral M; Pandian SK; Gowrishankar S
PLoS One; 2023; 18(12):e0295922. PubMed ID: 38153954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
